QUK

Human Leukocyte Antigen (Hla) Typing Companion Diagnostic Test

Product code
QUK
Device name
Human Leukocyte Antigen (Hla) Typing Companion Diagnostic Test
Device class
Class 2
21 CFR
21 CFR 866.5960
Medical specialty
Immunology
Marketing pathway
510(K)

FDA classification definition

A Human Leukocyte Antigen (HLA) Typing Companion Diagnostic (CDx) Test is a prescription genotyping or phenotyping assay intended for use as an aid in identifying patients who have specific HLA allele(s) or express specific HLA antigen(s) and may benefit from treatment with a corresponding therapeutic product, or are likely to be at increased risk for serious adverse reactions as a result of treatment with a corresponding therapeutic product.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QUK
Classification and pathway per current FDA publications. Data from openFDA (CC0).